✦ LIBER ✦

116. Safety of agalsidase alfa in Fabry disease patients under 7 years old

✍ Scribed by Uma Ramaswami; Rossella Parini; Michael Beck

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of agalsidase alfa in patients wi

✍ U Ramaswami; R Parini; C Kampmann; M Beck 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

One-year experience with agalsidase alfa

✍ C Spisni; R Di Vito; A Stingone; S Stuard; B D'angelo; L Caravelli; M Mascitti 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Pharmacokinetics of agalsidase alfa in m

✍ KS Loveday; C Brucato; T Colasurdo; R Gamble; J Lieb; M Sellos-Moura; T Schuetz; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Four-Year Prospective Clinical Trial of

✍ Raphael Schiffmann; Rick A. Martin; Tyler Reimschisel; Karen Johnson; Victoria C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Enzyme replacement therapy with agalsida

✍ A Mehta; M Beck; P Elliott; R Giugliani; A Linhart; G Sunder-Plassmann; R Schiff 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 253 KB

Clearing of globotriaosylceramide from e

✍ P. Rozenfeld; R. Ebner; O. Croxatto; C. Fossati 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB